Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER
-
Aehr Test Systems to Participate in 13th Annual NYC Summit
-
Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers
-
Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus
-
Kenorland Reports Regional Exploration Results from Northwestern Ontario Projects
-
TDb Split Corp. Class A Share Consolidation
-
Hair Growth Drug Safe at Low Doses for Breast Cancer Patients
-
Hiru Corporation (HIRU) Providing Clarity on Our Strategic Growth Plans
-
Over 2,000 Enterprises Worldwide Join China (Hainan) International Trade Fair for Tropical Agricultural Products
-
The U.S. Department of Homeland Security, Israel's National Cyber Directorate, and the BIRD Foundation, Announce a Cybersecurity Call for Proposals
-
Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate
-
Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns
-
Canopy Growth and Acreage Confirm Canopy USA's Completed Acquisition of Acreage
-
Omnicom to Acquire Interpublic Group to Create Premier Marketing and Sales Company
-
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
-
Syndax Announces Additional Positive Data for Revuforj® (revumenib) from AUGMENT-101 Trial in Relapsed or Refractory mNPM1 AML and BEAT AML Frontline Combination Trial
-
Aterian’s Mueller Living & PurSteam Brands Launch Three New Products
-
Ballard to Supply 8 MW of Fuel Cell Engines to Stadler for Californian Passenger Rail
-
ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymp
-
Relmada Therapeutics to Discontinue the Reliance II and Relight Phase 3 Studies of REL-1017
-
Independent Bank Corp. and Enterprise Bancorp, Inc. Sign Merger Agreement for Rockland Trust to Acquire Enterprise Bank
-
AST SpaceMobile Announces Definitive Commercial Agreement with Vodafone Through 2034
-
VR Resources Signs MOU with Lac Des Milles Lacs First Nation, Northwestern Ontario
-
IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization
-
Bowman Selected to Lead Engineering and Design on 64 MW Solar Installation
-
Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting
-
Chart Industries to Present at Wells Fargo 23rd Annual Midstream, Energy & Utilities Symposium
-
SL Green Announces Transactions at 100 Park Avenue
-
Aterian’s Mueller Living & PurSteam Brands Launch Three New Products
-
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference
-
Brixton Metals Drills 647.83m of 0.49% Copper Equivalent and Discovers a New Gold Zone 8.00m of 4.52 g/t Gold, 149 g/t Silver in the Camp Creek Corridor
-
Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian Cancer
-
LeddarTech Announces Collaboration with Texas Instruments for Advanced Driver Assistance Systems and Autonomous Driving Solutions
-
Bombardier Celebrates 200th Delivery of its Industry-Defining Global 7500 Aircraft, Underscoring Success of this Record-Setting Ultra-Long-Range Platform
-
Chart Industries to Present at Wells Fargo 23rd Annual Midstream, Energy & Utilities Symposium
-
The Public Interest Judicial Agreement signed by Orano Mining Ends PNF Proceedings
-
Alliance Witan PLC - Net Asset Value
-
Eighth Annual Puerto Rico Blockchain Week Features Four Conferences, Plus Side Events and Parties, to Discuss and Celebrate $100,000 Bitcoin Price
-
Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA
-
AlphaMind Launchpad Pioneers a New Era with $1,000,000 Hardcap Success for $EYWA IDO
-
Defense Metals Announces Release Date of its Wicheeda Rare Earth Element Project PFS
-
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
-
Gala Film Announces the Launch of Revolutionary $FILM Token
-
Mason Capital Management-Led Consortium Completes Acquisition of CB&I
-
PAINTEQ SECURES GROUNDBREAKING PATENT FOR LINQ® TECHNOLOGY, ADVANCING PRECISION AND EFFICIENCY IN SI JOINT FUSION
-
Transactions in connection with share buyback programme
-
American bespoke Coaching and Psychiatry practice The Open Sea Institute showcased in new book to celebrate 120 years of Rolls-Royce
-
Solu Therapeutics Presents Positive Preclinical Data on STX-0712 for Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting
-
Extreme Introduces Extreme Platform ONE: Integrated AI-Powered Automation That Radically Simplifies the Customer Experience in Enterprise Networking and Security
-
EnviroGold Global to Present at the Precious Metals & Critical Materials Virtual Investor Conference December 10th
